Fangyuan Qu

Enhancing prediction of pathological complete response to neoadjuvant immunotherapy in non-small cell lung cancer by whole-lung radiomics

To evaluate the utility of whole-lung radiomics for predicting pathological complete response (pCR) to neoadjuvant immunotherapy in patients with non-small cell lung cancer (NSCLC), and further explore whether integrating whole-lung radiomics with tumor-specific radiomics could e...